Brainomix completes £14m Series C led by Parkwalk Advisors to advance AI imaging technology in healthcare

Brainomix develops AI-powered medical imaging software for stroke and lung disease, helping clinicians diagnose conditions faster and make better treatment decisions using automated biomarkers.